INSTITUT CURIE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1909-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.curie.fr
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
Phase 1
Active, not recruiting
- Conditions
- Lymphoma, Large B-Cell, DiffuseCentral Nervous System Neoplasms, Primary
- Interventions
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 118
- Registration Number
- NCT04446962
- Locations
- 🇫🇷
CHU Amiens, Amiens, France
🇫🇷CHU Besançon, Besançon, France
🇫🇷CH Colmar, Colmar, France
Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
Not Applicable
Recruiting
- Conditions
- Uveal Melanoma
- Interventions
- Other: Blood test
- First Posted Date
- 2020-06-11
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 700
- Registration Number
- NCT04424719
- Locations
- 🇫🇷
Institut Curie, Paris, France
Study on Skin Toxicities Induced by Cancer Treatments
Not Applicable
Completed
- Conditions
- Lung CancerSolid Tumor, AdultBreast Cancer
- Interventions
- Other: Evaluation on skin toxicities
- First Posted Date
- 2020-05-27
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 292
- Registration Number
- NCT04402606
- Locations
- 🇫🇷
Institut Curie, Paris, France
COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur
Not Applicable
Completed
- Conditions
- Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection
- Interventions
- Diagnostic Test: Blood samples (collection of 5 mL of blood in a dry tube)Diagnostic Test: Nasopharyngeal swabs
- First Posted Date
- 2020-04-30
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 1971
- Registration Number
- NCT04369066
- Locations
- 🇫🇷
Institut Curie, Paris, France
🇫🇷Institut Pasteur, Paris, France
MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery
- First Posted Date
- 2020-03-30
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 182
- Registration Number
- NCT04327063
- Locations
- 🇫🇷
Institut Curie, Paris, France
🇫🇷Centre Jean Perrin, Clermont-Ferrand, France
🇫🇷Hopital Tenon, Paris, France
Transcutaneous Breast Cancer Diagnosis by Canine Odorology
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Diagnostic Test: Odour sampling
- First Posted Date
- 2020-01-03
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 196
- Registration Number
- NCT04217109
- Locations
- 🇫🇷
Centre Hospitalier Universitaire, Limoges, France
🇫🇷Centre Hospitalier Valenciennes, Valenciennes, France
🇫🇷Centre République, Clermont-Ferrand, France
Breast Cancer Risk After Diagnostic Gene Sequencing
Not Applicable
Completed
- Conditions
- Genetic Predisposition to Disease
- Interventions
- Genetic: BRIDGES gene panel testingGenetic: Breast cancer risk polygenic risk score (PRS)Behavioral: Questionnaires
- First Posted Date
- 2019-10-31
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 405
- Registration Number
- NCT04145817
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, Germany
🇫🇷Institut Curie, Paris, France
Communicating With Patients on Cancer Resistance to Treatment: the Development of a Communication Tool. (HECTOR)
Not Applicable
Active, not recruiting
- Conditions
- Luminal B Breast CancerMetastatic Uveal MelanomaTriple Negative Breast CancerPediatric Cancer
- Interventions
- Behavioral: QuestionnairesOther: Focus GroupOther: DELPHI Consensus MethodBehavioral: Semi-structured individual interviews
- First Posted Date
- 2019-10-07
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 190
- Registration Number
- NCT04118062
- Locations
- 🇫🇷
Institut Curie, Paris, France
Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma
- Conditions
- Uveal Melanoma
- First Posted Date
- 2019-05-28
- Last Posted Date
- 2019-10-31
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 100
- Registration Number
- NCT03964298
- Locations
- 🇫🇷
Rodrigues, Paris, Ile-de-France, France
Impact of Sick Peer Relation on Adaptation to Disease and on Treatment of Cancer-suffering Adolescents & Young Adults
Not Applicable
Active, not recruiting
- Conditions
- Adolescent BehaviorCancerYoung Adult
- Interventions
- Other: Questionnaires set all 3 months
- First Posted Date
- 2019-05-28
- Last Posted Date
- 2023-12-04
- Lead Sponsor
- Institut Curie
- Target Recruit Count
- 100
- Registration Number
- NCT03964116
- Locations
- 🇫🇷
INSTITUT CURIE - site Paris, Paris, Ile De France, France
🇫🇷Centre Leon Berard, Lyon, France
© Copyright 2025. All Rights Reserved by MedPath